Summary: Serum and plasma myoglobin and creatine kinase-MB catalytic activity were analysed in 157 patients admitted within 2 hours of the onset of ehest pain (58 were retrospectively recognized s acute myocardial infarction).
Introduction
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t h e assay O f plasma instead of serum myoglobin (13), Until 4-5 years ago, however, the methods for serum since preliminary studies showed a high correlation bemyoglobm assay were a radioimmunoassay (4) scarcely twe^n plasma and serum myoglobin immunonephelosuitable for an emergency laboratory, and the latex ag-nietric assays. glutination method (5, 6), a semiquantitative procedure We report ^^ obtained oyer ft period Qf twQ yeafs with an insatisfactory diagnostic sensitivity. for ^ eafly diagnosis Qf acute myocardia , infarction in More recently, a turbidimetric assay (7) with excellent a group of non-selected ehest pain patients, using the analytical performance (8) and a nephelometric assay measurement of plasma and serum myoglobin and the (9) have been suggested for serum myoglobin assay, and assay of creatine kinase-MB activity.
Materials and Methods

Paticnts
Wc studied 157 patients admitted within 2 hours from the onset of ehest pain; 101 were males, aged between 33 and 72 (median 58) and 56 were females (38 to 80 years, median 61). The studied population was referred from the emergency cardiology department of the tvvo major hospitals of our region, and includes only those subjects with a high prediction of acute myocardial infarction.
Retrospectively, 58 patients (41 males and 17 females) were diagnosed s affected by aeute myocardial infarction according to the World Health Organization criteria (14) based on clinical, electrocardiographic and enzymatic data; the results of myoglobin were not provided to the physicians; 38 patients (66%) with acute myocardial infarction received intravenous tlirombolytic therapy; the others were not given the therapy, because of various contraindications.
Among non-acute myocardial infarction subjects, 28% were suffering from unstable angina pectoris, 23% from pneumonitis or pulm onary embolism, 17% from pericarditis, 16% from gastric ulcer or gastritis; for the remaining subjects there is no definite diagnosis. None of the patients had received intramuscular injections on admission, and none had clinical fmdings of skeletal muscle injury.
For each patient, blood was sampled 3, 6, and 9 hours after the onset of ehest pain, using both a lithium heparin vacutainer (Becton Dickinson) and a vacutainer with no anticoagulant. The samples were centrifuged (5 min at 2500 g) and processed for the analyses of creatine kinase-MB and myoglobin.
Methods
Serum and plasma creatine kinase activity was analysed at 37 °C on the Spectrum 2 analyser with reagents from Abbott (North Chicago, IL) using the immunoinhibition procedure (Abbott) for the estimation of creatine kinase-MB isoenzyme activity.
Serum and plasma myogiobin were analysed using the irnmunonephelometric (NA-Latex, Behringwerke, Marburg, Germany) method.
Tab. l Correlation (regression analysis, y = plasma; χ = serurn) between serurn and plasma assays of myoglobin and creatine kinase-MB (y = a + bx) 
Results
The correlation between serum and plasma values of myoglobin and creatine kinase-MB was tested on 48 samples obtained from patients with acute myocardial infarction; in both cases, the correlation was excellent (tab. 1) for analytical values extending over a veiy wide r nge.
The intra^day and between days imprecision of the methods for myoglobin analysis (CV% =3.9 and 7.8 respectively), and for creatine kinase activity estimation (CV% = 5.1 and 8.9 respectively) indicates the low variability of both the methods. Tables 2 to 4 report the values for diagnostic sensitivity and specificity and positive and negative predictivity of plasma myoglobin and creatine kinase-MB in the discrimination between acute myocardial infarction and non-ac te myocardial infarction ehest pain patients, tested 3, 6 and 9 hours from the onset of ehest pain. The number of non-acute myocardial infarction control patients gradually decreases; this is due to the percentage of subjects dismissed from the emergency cardi- ology department after the exclusion of acute myocardial infarction.
For myoglobin and creatine kinase-MB we used a cutoff value of 100 g/l, and 5% of total enzyme activity, respectively. These values had been previously calculated with the receiving operator characteristic curve 1 analysis äs the best discriminating cut-off between acute ! myocardial infarction and non-acute myocardial infarc-! tion ehest pain subjects (2) , and are used routinely in 1 our laboratory.
Plasma myoglobin appeared to be a more efficient biochemical marker than creatine kinase-MB, being increased in 90% of acute myocardial infarction patients 6 hours after the onset of ehest pain, with a diagnostic specificity of 100% for non-acute myocardial infarction t ehest pain patients.
Discussion
In recent years, the use of thrombplytic therapy has reduced myocardial damage and mortality in acute myocardial infarction patients; however, such therapy must be used during the first hours after the onset of myocard ial necrosis, thüs requiring a very early and specific biochemical diagnosis, particularly in patients with unclear electrocardiographic data.
An early biochemical diagnosis of acute myocardial infarction cannot be based on sefum creatine kinase-MB activity, since this marker peak § too late during acute myocardial infarction. Our data confirm that the release of myoglobin in acute myocardial infarction patients is an earlier event than creatine kinase-MB release, äs previously described on a large population (15) ; in fact, 40% and 90% of acute myocardial infarction patients can be identified with the plasma myoglobin assay after three and six hours frorn the onset of Symptoms, respeetively, while the percentage of acute myocardial infarctions identified with creatine kinase-MB activity assay is significantly lower. These results are particularly interesting, because electrocardiographic data are inconclusive for a certain percentage of acute myocardial infarction patients; in our population (data not shown), the results of electrocardiography were inadequate for -a conclusive diagnosis in about 10% of acute myocardial infarction cases. In addition, the evaluation of myoglobin has been reported äs a useful marker for evaluation the myocardial reperfusion after thrombolytic therapy (16) .
Recently, Mair et al. (17) reported that the mass concentration of creatine kinase-MB provides an earlier diagnosis of acute myocardial infarction than does its catalytic concentration. Our preliminary results on a small sample of acute myocardial infarction cases (data not shown) confirm these results.
Our two-years experience has confirmed that the immunonephelometric procedure for myoglobin analysis makes an impörtant contribution to diagnosis. Evaluated against classical quality control methods, the procedure was shown to be precise and accurate. It is also rapid, so that were able introduce the procedure into the laboratory routine äs an alternative to the previously used radioimmunoassay method. Cut-off values of 100 g/l for myoglobin and 5% of total enzyme activity for creatine kinase-MB, previously revealed by the receiver operating characteristic curve analysis (2), gave the best discrimination of acute myocardial infarction frorn non-acute myocardial infarction ehest pain patients in our population; this cut-off, recently confirmed by the group ofBakker (18) , is slightly higher than the Value of 90 g/l suggested by the producer of the immunonephelometric kit for myoglobin analysis, and which has been evaluated in a healthy control reference population. A higher cut-off value gives a diagnostic specificity of 100% for discrimination of the acute myocardial infarction group from non-acute myocardial infarction patients. Also, during our two years study, myoglobin values higher than 100 g/l were observed in a small percentage of patients with skeletal muscle injury (data not reported), but such diseases rarely require a discrimination from acute myocardial infarction. However, when the ehest is accompanied by clinically evident muscular damage, it should be borne in mind that serum/plasma myoglobin or creatine kinase-MB can also be released from skeletal muscle. In these cases, it is important to consider all the clinical, electrocardiographic and laboratory data together, rather than a single biochemical marker.
At the moment, myoglobin appears to be the most reliable biochemical marker for the early diagnosis of acute myocardial infarction. Other approaches have been recently suggested, such äs creatine kinase isoform analysis (19) , particularly the serum MM3/MM1 ratio, whose alteration is a very early event in acute myocardial infarction patients. However, the use of this approach is limited, since serum creatine kinase isoforms can only be analysed by electrophoresis, isoelectric focusing and liquid Chromatographie methods, which are inadequate for a rapid routine analysis. The use of the immunological procedure is still questionable, since the group of Suzuki (20) described various monoclonal antibodies for creatine kinase isoforms with different analytical specificities.
The other result of our study is the very high correlation between serum and plasma myoglobin and creatine kinase-MB, obtained in a large groüp of patients with values of the two analytes ranging over a wide ränge of values. This result confirms our preliminary observation (13) that the use of lithium heparin äs anticoagulant does not affect the myoglobin and creatine kinase-MB immunological assays, and does n,qt irihibit creatine kinase enzyme activity. These data agree with another preliminary result from 10 acute myocardial infarction cases (8) and with a study published by the gixmp ofMair (15) which used a different anticoagulant.
The use of plasma instead of serum myoglobin is a useful approach, reducing by about 20 minutes the time required for a conclusive diagnosis of acute myocardial infarction; in addition, the same sample can also be used for creatine kinase-MB analysis.
We conclude that the nephelometric assay of plasma myoglobin should be included, together with immunological creatine kinase-MB analysis, äs a primary contributory tool in the protocols for the diagnosis of acute myocardial infarction in patients on their first day of admission.
